MedTrace Logo

Interactions of Medicine and Exercise With Meal Timing

NCT04477590 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-08-25

No results posted yet for this study

Summary

To analyze the effects of altering the time of ingestion of participants' habitual medication (i.e., metformin, statins, ARAII/IACE) and meals around the time of exercise training (exercise fasted or fed) on the improvement of metabolic syndrome factors (hypertension, insulin sensitivity, dyslipidemia, and obesity). There will be a preliminary study of the effects of training "time-of-day" on the primary study outcomes.

Conditions

  • Metabolic Syndrome, Protection Against
  • Exercise Training
  • Metformin
  • Statins
  • Angiotensin-Converting-Enzyme Inhibitor
  • Fasting, Intermittent
  • Angiotensin Hypertension

Interventions

DRUG

EXERCISE TRAINING WITH OR WITHOUT MEDICATION

A group will train 30 min after taking their habitual dose of medicine (MEDICATED train) while another group will train after taking a placebo (NON-MEDICATED train) and will receive their medication after training.

Sponsors & Collaborators

  • Ministerio de Economía y Competitividad, Spain

    collaborator OTHER_GOV

  • Servicio de Salud de Castilla-La Mancha

    collaborator UNKNOWN

  • University of Castilla-La Mancha

    lead OTHER

Principal Investigators

  • RICARDO M Mora-Rodriguez, PhD · University of Castilla-La Mancha

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-07
Primary Completion
2024-05-30
Completion
2024-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477590 on ClinicalTrials.gov